首页> 外文期刊>Analytical methods >Multi-screening of beta-lactam antibiotics for beta-lactamase resistance by means of a paper-based analytical device with a 4-(2-pyridylazo)resorcinol (PAR)-Hg2+ complex
【24h】

Multi-screening of beta-lactam antibiotics for beta-lactamase resistance by means of a paper-based analytical device with a 4-(2-pyridylazo)resorcinol (PAR)-Hg2+ complex

机译:β-内酰胺酶抗生素的多筛选β-内酰胺酶抗生素借助于具有4-(2-吡啶氧基)间苯二酚(Par)-HG2 +复合物的纸 - 含有纸 - 内酰胺酶抗性的β-内酰胺酶抗性。-HG2 +复合物

获取原文
获取原文并翻译 | 示例
           

摘要

beta-Lactam antibiotics are widely used for the treatment of bacterial infections; however, an increase in the number of antibiotic-resistant bacteria, which produce beta-lactamases that inactivate beta-lactam antibiotics, can lead to serious untreatable diseases. Thus, proper prescribing of antibiotics and the development of new antimicrobial agents with strong resistance to hydrolysis by beta-lactamases can be a solution to reduce antibiotic resistance and treat various bacterial infections. Accordingly, simple and rapid methods for the screening of antibiotics that show beta-lactamase resistance are required. Therefore, we designed a multi-channel microfluidic paper-based analytical device (mPAD) for colorimetric screening of beta-lactam antibiotics for beta-lactamase resistance; the mPAD, created by modifying paper with self-assembling organosilane and a 4-(2-pyridylazo) resorcinol (PAR)-Hg2+ complex, can screen beta-lactam antibiotics for hydrolytic resistance to multiple beta-lactamases at once. To demonstrate its suitability for this task, we confirmed the resistance of already studied beta-lactam antibiotics-penicillin G, cloxacillin, and ceftazidime-toward different classes of beta-lactamases (penicillinase, TEM-1, and CTX-M-1) using the mPAD. Based on ligand exchange between hydrolyzed beta-lactam antibiotics and PAR in the PAR-Hg2+ complex, colorimetric detection of the relative susceptibilities of beta-lactam antibiotics to a beta-lactamase is possible even with the naked eye in only 10 minutes. The portable and equipment-free mPAD allows for simple multi-screening of diverse classes of beta-lactam antibiotics for beta-lactamase resistance.
机译:β-内酰胺抗生素广泛用于治疗细菌感染;然而,产生抗生素抗性细菌数量的增加,其产生β-内酰胺酶,其灭活β-内酰胺抗生素,可导致严重的无法治愈的疾病。因此,对抗生素的适当处方和开发具有强抗β-内酰胺酶的强耐水解性的新抗菌剂可以是降低抗生素抗性并治疗各种细菌感染的溶液。因此,需要筛选显示β-内酰胺酶抗性的抗生素的简单且快速的方法。因此,我们设计了一种用于比色筛选的基于多通道微流体纸的分析装置(MPAD),用于β-内酰胺抗生素的β-内酰胺酶抗性;通过用自组装有机硅烷和4-(2-吡啶氮氮杂)间苯二酚(Par)-Hg2 +复合物的改性纸产生的MPAD,可以筛选β-内酰胺抗生素,同时对多种β-内酰胺酶进行水解抗性。为了证明其适用于这项任务,我们证实已经研究了β-内酰胺抗生素-Penicillin G,克罗克里林邦和头孢唑胺 - 朝向不同类β-内酰胺(青霉素酶,TEM-1和CTX-M-1)的抗性MPAD。基于水解的β-内酰胺抗生素和在PAR-HG2 +复合物中的配体交换,即使在仅10分钟内肉眼也可以在比色度检测β-内酰胺抗生素对β-内酰胺酶的相对敏感性。便携式和设备的MPAD允许简单的多种类别的β-内酰胺抗生素进行多种多类β-内酰胺酶抗性。

著录项

  • 来源
    《Analytical methods》 |2019年第13期|共6页
  • 作者单位

    Gwangju Inst Sci &

    Technol Dept Chem 123 Cheomdangwagi Ro Gwangju 61005 South Korea;

    Gwangju Inst Sci &

    Technol Dept Chem 123 Cheomdangwagi Ro Gwangju 61005 South Korea;

    Gwangju Inst Sci &

    Technol Dept Chem 123 Cheomdangwagi Ro Gwangju 61005 South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分析化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号